Community Schedule

Enter at least 4 characters

3 results showing for: 'pertussis'

  1. Vaccinations
Diphtheria, tetanus and pertussis vaccine    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 303.
- Only on a prescription
- No patient co-payment payable
  • Inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid, 8 mcg pertussis toxoid, 8 mcg pertussis filamentous haemagglutinin and 2.5 mcg pertactin in 0.5 ml prefilled syringe
    • Brand Fully subsidised brand. Boostrix
    • Pharmacode2459418
    • Subsidy $0.00
    • Measure / Qty per 10

  1. Funded for any of the following criteria:

    1. A single dose for pregnant women in the second or third trimester of each pregnancy; or

    2. A single dose for parents or primary caregivers of infants admitted to a Neonatal Intensive Care Unit or Specialist Care Baby Unit for more than 3 days, who had not been exposed to maternal vaccination at least 14 days prior to birth; or

    3. A course of up to four doses is funded for children from age 7 up to the age of 18 years inclusive to complete full primary immunisation; or

    4. An additional four doses (as appropriate) are funded for (re-)immunisation for patients post haematopoietic stem cell transplantation or chemotherapy; pre or post splenectomy; pre- or post solid organ transplant, renal dialysis and other severely immunosuppressive regimens; or

    5. A single dose for vaccination of patients aged from 65 years old; or

    6. A single dose for vaccination of patients aged from 45 years old who have not had 4 previous tetanus doses; or

    7. For vaccination of previously unimmunised or partially immunised patients; or

    8. For revaccination following immunosuppression; or

    9. For boosting of patients with tetanus-prone wounds.

    Notes: Please refer to the Immunisation Handbook for appropriate schedule for catch up programmes.

  2. Contractors will be entitled to claim payment from the Funder for the supply of diphtheria, tetanus and pertussis vaccine to patients eligible under the above criteria pursuant to their contract with Health New Zealand (Health NZ) for subsidised immunisation, and they may only do so in respect of the diphtheria, tetanus and pertussis vaccine listed in the Pharmaceutical Schedule.

  3. Contractors may only claim for patient populations within the criteria that are covered by their contract, which may be a sub-set of the population described in paragraphs 1 – 9 above.

  1. Vaccinations
Diphtheria, tetanus, pertussis and polio vaccine    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 304.
- Only on a prescription
- No patient co-payment payable
  • Inj 30 IU diphtheria toxoid with 40 IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagglutinin, 8 mcg pertactin and 80 D-antigen units poliomyelitis virus in 0.5ml syringe
    • Brand Fully subsidised brand. Infanrix IPV
    • Pharmacode2086417
    • Subsidy $0.00
    • Measure / Qty per 10

  1. Funded for any of the following:

    1. A single dose for children up to the age of 7 who have completed primary immunisation; or

    2. A course of four vaccines is funded for catch up programmes for children (to the age of 10 years) to complete full primary immunisation; or

    3. An additional four doses (as appropriate) are funded for (re-)immunisation for people post HSCT, or chemotherapy; pre- or post splenectomy; pre- or post solid organ transplant, renal dialysis and other severely immunosuppressive regimens; or

    4. Five doses will be funded for children requiring solid organ transplantation.

  2. Contractors will be entitled to claim payment from the Funder for the supply of Diphtheria, tetanus, pertussis and polio vaccine to people eligible under the above criteria pursuant to their contract with Health New Zealand (Health NZ) for subsidised immunisation, and they may only do so in respect of the Diphtheria, tetanus, pertussis and polio vaccine listed in the Pharmaceutical Schedule.

  3. Contractors may only claim for populations within the criteria that are covered by their contract, which may be a sub-set of the population described in paragraph A above.

Note: Please refer to the Immunisation Handbook for appropriate schedule for catch up programmes.

  1. Vaccinations
Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 304.
- Only on a prescription
- No patient co-payment payable
  • Inj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen, 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe
    • Brand Fully subsidised brand. Infanrix-hexa
    • Pharmacode2459396
    • Subsidy $0.00
    • Measure / Qty per 10

  1. Funded for children meeting any of the following criteria

    1. Up to four doses for children under the age of 10 years for primary immunisation; or

    2. An additional four doses (as appropriate) for (re-)immunisation of children under the age of 18 years post haematopoietic stem cell transplantation; or

    3. An additional four doses (as appropriate) for (re-)immunisation of children under the age of 10 years who are post chemotherapy; pre or post splenectomy; undergoing renal dialysis and other severely immunosuppressive regimens; or

    4. Up to five doses for children under the age of 10 years receiving solid organ transplantation.

  2. Contractors will be entitled to claim payment from the Funder for the supply of Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type b vaccine to people eligible under the above criteria pursuant to their contract with Health New Zealand (Health NZ) for subsidised immunisation, and they may only do so in respect of the Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type b vaccine listed in the Pharmaceutical Schedule.

  3. Contractors may only claim for populations within the criteria that are covered by their contract, which may be a sub-set of the population described in paragraph A above.

Note: A course of up-to four vaccines is funded for catch up programmes for children (up to and under the age of 10 years) to complete full primary immunisation. Please refer to the Immunisation Handbook for the appropriate schedule for catch up programmes.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply



Email enquiry@pharmac.govt.nz to provide feedback: compliments, suggestions and complaints.